212 related articles for article (PubMed ID: 12676255)
1. A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.
Chua DT; Sham JS; Au GK
Oral Oncol; 2003 Jun; 39(4):361-6. PubMed ID: 12676255
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
Chua D; Wei WI; Sham JS; Au GK
Jpn J Clin Oncol; 2008 Apr; 38(4):244-9. PubMed ID: 18407933
[TBL] [Abstract][Full Text] [Related]
3. Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.
Peng PJ; Ou XQ; Chen ZB; Liao H; Peng YL; Wang SY; Zhang HY; Lin Z
Cancer Chemother Pharmacol; 2013 Aug; 72(2):323-8. PubMed ID: 23728706
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.
Li YH; Wang FH; Jiang WQ; Xiang XJ; Deng YM; Hu GQ; Xu DM; Chen Y; Lin Q; He YJ
Cancer Chemother Pharmacol; 2008 Aug; 62(3):539-44. PubMed ID: 18172651
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study.
Ciuleanu E; Irimie A; Ciuleanu TE; Popita V; Todor N; Ghilezan N
J BUON; 2008; 13(1):37-42. PubMed ID: 18404784
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study.
Jakob A; Bokemeyer C; Knop S; Schupp M; Mayer F; Kanz L
Anticancer Drugs; 2002 Apr; 13(4):405-10. PubMed ID: 11984086
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy.
Chua DT; Kwong DL; Sham JS; Au GK; Choy D
Eur J Cancer; 2000 Apr; 36(6):736-41. PubMed ID: 10762745
[TBL] [Abstract][Full Text] [Related]
8. Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy.
Reichardt P; Von Minckwitz G; Thuss-Patience PC; Jonat W; Kölbl H; Jänicke F; Kieback DG; Kuhn W; Schindler AE; Mohrmann S; Kaufmann M; Lück HJ
Ann Oncol; 2003 Aug; 14(8):1227-33. PubMed ID: 12881384
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.
Errihani H; M'rabti H; Ismaili N; Inrhaoun H; Elghissassi I
Int J Gynecol Cancer; 2011 Feb; 21(2):373-7. PubMed ID: 21270619
[TBL] [Abstract][Full Text] [Related]
10. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.
Altundag K; Aksoy S; Gullu I; Altundag O; Ozyar E; Yalcin S; Cengiz M; Akyol F
Med Oncol; 2004; 21(3):211-5. PubMed ID: 15456947
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
Gao Y; Huang HQ; Bai B; Cai QC; Wang XX; Cai QQ
Expert Opin Pharmacother; 2014 Feb; 15(2):163-71. PubMed ID: 24295173
[TBL] [Abstract][Full Text] [Related]
12. A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma.
You B; Le Tourneau C; Chen EX; Wang L; Jarvi A; Bharadwaj RR; Kamel-Reid S; Perez-Ordonez B; Mann V; Siu LL
Am J Clin Oncol; 2012 Jun; 35(3):255-60. PubMed ID: 21358293
[TBL] [Abstract][Full Text] [Related]
13. A pilot phase II study of capecitabine in advanced or recurrent breast cancer.
Saeki T; Kimura T; Toi M; Taguchi T
Breast Cancer; 2006; 13(1):49-57. PubMed ID: 16518062
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.
Chua DT; Yiu HH; Seetalarom K; Ng AW; Kurnianda J; Shotelersuk K; Krishnan G; Hong RL; Yang MH; Wang CH; Sze WK; Ng WT
Head Neck; 2012 Sep; 34(9):1225-30. PubMed ID: 22076785
[TBL] [Abstract][Full Text] [Related]
16. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571
[TBL] [Abstract][Full Text] [Related]
17. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.
Chan AT; Hsu MM; Goh BC; Hui EP; Liu TW; Millward MJ; Hong RL; Whang-Peng J; Ma BB; To KF; Mueser M; Amellal N; Lin X; Chang AY
J Clin Oncol; 2005 May; 23(15):3568-76. PubMed ID: 15809453
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients.
Blum JL; Dieras V; Lo Russo PM; Horton J; Rutman O; Buzdar A; Osterwalder B
Cancer; 2001 Oct; 92(7):1759-68. PubMed ID: 11745247
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.
Blum JL; Jones SE; Buzdar AU; LoRusso PM; Kuter I; Vogel C; Osterwalder B; Burger HU; Brown CS; Griffin T
J Clin Oncol; 1999 Feb; 17(2):485-93. PubMed ID: 10080589
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma.
Péron J; Poupart M; Ceruse P; Ramade A; Girodet D; Zrounba P; Fayette J
Anticancer Drugs; 2012 Nov; 23(10):1107-11. PubMed ID: 22954504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
